We use cookies to personalise content and ads, to provide social media features and to analyse our traffic. We may also share information about your use of our site with our social media, advertising and analytics partners. Read more about our Privacy Policy.

I got it!


Mr Bob Clay

President & Managing Director

Bob Clay established his own regulatory consultancy practice through Highbury Regulatory Science. Prior to this, he was a VP global regulatory affairs at AstraZeneca with responsibility for oncology, infection and personalised healthcare. Bob is the chief regulatory officer at Kinapse and a member of the board of TOPRA (The Organisation of Professional Regulatory
Affairs). He is a member of the Expert Scientific Advisory Committee for Medicines for Malaria Venture (MMV) and several working groups at CPTR (Critical Path to TB Regimens). Bob is a pharmacist with more than 30 years’
experience in drug development; leading the global regulatory approval of many products across a range of therapy areas including metabolic diseases, neuroscience, cancer and infection. Bob has held significant leadership roles
in regulatory affairs in regional and global functions at several companies including AstraZeneca and Pfizer. Bob has had a long-standing interest in the regulatory aspects of adaptive trial designs, including membership of the PhRMA working group.

Similar Speakers

Ms Haza Marion
keynote speaker


Mr sam vaknin
Keynote speaker, Workshop


Mr Intima Alrimawi
Keynote Speaker


Mr Dan Oleary


Mr Michael Brodsky


Mr John N Zorich
Statistical Consultant & Trainer


Mr Ricardo Valls


Mr Camelia-Margareta Bogdanici
Organizing Member


Mr Jean-Claude Combadazou
Dental Surgeon / Speaker


Sponsors in Medicine

Register for free to access the Speakers Directory

Search by policy area and keyword 3152 professional speakers from Europe and beyond